Export Control Update and Overview

Rescinded: Section 480-20: Guidelines for Compliance with Export Control Regulations Due to the evolving export control regulatory environment, UCI is rescinding Section 480-20: Guidelines for Compliance with Export Control Regulations.  Effective immediately, the University of California Policy on Export Control will replace Section 480-20. This policy addresses UC’s commitment to ensuring compliance with U.S. export control laws.…

Read More

Department of Energy Conflict of Interest Policy

Implementation Date: June 18th, 2022 The Department of Energy (DOE) has announced its Interim Conflict of Interest Policy Requirements for Financial Assistance, which applies to DOE financial assistance awards except Office of Indian Energy or Phase 1 Small Business Innovation Research/Small Business Technology Transfer applications.  The interim policy primarily mirrors the Public Health Service (PHS) conflict of…

Read More

Kuali Research Protocols (KRP): Administrative Determination vs a Protocol for IRB Review

There are 3 types of applications in KRP.   Keep this reference on hand when navigating human subject research at UCI. Non-Human Subjects Research (NHSR) Self-Determination Exempt Self-Determination UCI allows Exempt Self-Determination for Categories 1-4ii. There are exceptions for certain populations and procedures. Exempt Research that Requires IRB Approval Exempt research that is not eligible for…

Read More

Phase 4 Research Transitioning Starts on June 22, 2021

Dear Colleagues, On June 22, 2021, UCI will begin its gradual transition to Phase 4 research.  This is the final phase in reopening the UCI research enterprise. In summary, Phase 4 research permits all research activities, as well as all types of invited guests and visitors.  This last phase aligns safety and mitigation requirements with…

Read More

Updated Conflict of Interest Forms

Reminder: Implementation of new COI Forms starts today, June 1, 2021 The Office of Research announced the release of updated Conflict of Interest (COI) Forms and procedures in April that will be required starting today, June 1st, 2021.  See here for more information. Please refer to our website for the current versions of the COI Forms.  Starting today, the COI staff…

Read More

Update on Pilot Phase of Revised COI Forms

Four weeks left to use the old COI Forms On April 5, 2021, the Office of Research announced the release and pilot phase of the updated COI Forms that will be required starting June 1st, 2021.  Thanks to individuals already using the new forms, the COI team already made some improvements to them.  If you…

Read More

KR Protocols Launch and Impact on Research

KR Protocols Launch and Impact on Research Kuali Research (KR) Protocols module provides key improvements to UCI’s Institutional Review Board (IRB) and Human Stem Cell Research Oversight (hSCRO) committee processes Phased Timeline May 2021: Launch of the Non-Human Subjects Research (NHSR) form in KR Protocols June 2021: Limited IRB submissions allowed only September 2021: Full IRB…

Read More

Updated Conflict of Interest Forms

Implementation Date: June 1st, 2021 To facilitate the conflict of interest review process, the Conflict of Interest Oversight Committee (COIOC) revised the Conflict of Interest (COI) Form questions to promote clarity and focus on gathering only the information necessary for their review.  These new forms are already available online and we encourage you start using…

Read More

Phase 3 Research Reference Guide

Dear Colleagues, As a follow-up to my email on March 30th announcing UCI’s upcoming move to Phase 3 Research, I would like to call your attention to a tool newly created by EH&S:  The Phase 3 Research Reference Guide. This guide provides links to useful EH&S resources that will help you transition safely and efficiently to Phase 3. This…

Read More

Phase 3 Research Transitioning Starts on April 5, 2021

Dear Colleagues, I am pleased to announce that on April 5, 2021, UCI will begin transitioning to Phase 3 research.  A confluence of factors makes this possible – the most important being high compliance levels with safety protocols, protective measures, and with approved Phase 1 and 2 research plans, as verified by Environmental Health &…

Read More